McCourt Marion sold REGN
September 3, 2026 · Form 4 insider transaction
McCourt Marion sold 1,131 shares of Regeneron Pharmaceuticals, Inc. at $857.39 per share, a transaction worth $969.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,131
Price
$857.39
Total value
$969.7K
InsiderMcCourt Marion
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 3, 2026
Filing dateSeptember 3, 2026
Shares owned after12,003
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 17, 2026.